AbsEn.i
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « protein »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
protective < protein < proteinase  Facettes :

List of bibliographic references indexed by protein

Number of relevant bibliographic references: 123.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000009 (2021) Rashed Noor [Bangladesh]Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic.
000127 (2021) Thirumal Kumar D [Inde] ; Nishaat Shaikh [Inde] ; Udhaya Kumar S [Inde] ; George Priya Doss C [Inde] ; Hatem Zayed [Qatar]Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2.
000129 (2021) Sinosh Skariyachan [Inde] ; Dharshini Gopal [Inde] ; Aditi G. Muddebihalkar [Inde] ; Akshay Uttarkar [Inde] ; Vidya Niranjan [Inde]Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies.
000130 (2021) Yudibeth Sixto-L Pez [Mexique] ; José Correa-Basurto [Mexique] ; Martiniano Bello [Mexique] ; Bruno Landeros-Rivera [France] ; Jose Antonio Garz N-Tiznado [Mexique] ; Sarita Monta O [Mexique]Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population.
000174 (2021) Abdo A. Elfiky [Égypte]SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective.
000203 (2021) F O Shode [Afrique du Sud] ; A S K. Idowu [Afrique du Sud] ; O J Uhomoibhi [Afrique du Sud] ; S. Sabiu [Afrique du Sud]Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2.
000241 (2021) Walter Filgueira De Azevedo Junior ; Gabriela Bitencourt-Ferreira ; Joana Retzke Godoy ; Hilda Mayela Aran Adriano ; Wallyson André Dos Santos Bezerra [États-Unis] ; Alexandra Martins Dos Santos Soares [États-Unis]Protein-ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2.
000263 (2021) Fouzia Mesli [Algérie] ; Meriem Ghalem [Algérie] ; Ismail Daoud [Algérie] ; Said Ghalem [Algérie]Potential inhibitors of angiotensin converting enzyme 2 receptor of COVID-19 by Corchorus olitorius Linn using docking, molecular dynamics, conceptual DFT investigation and pharmacophore mapping.
000264 (2021) Yanqiang Han ; Zhilong Wang ; Jiahao Ren ; Zhiyun Wei ; Jinjin Li [République populaire de Chine]Potential inhibitors for the novel coronavirus (SARS-CoV-2).
000271 (2021) Ahmed A. Ishola [Nigeria] ; Kayode E. Adewole [Nigeria] ; Habibu Tijjani [Nigeria] ; Suliat I. Abdulai [Nigeria] ; Nnaemeka T. Asogwa [Nigeria]Phylogenic analysis of coronavirus genome and molecular studies on potential anti-COVID-19 agents from selected FDA-approved drugs.
000277 (2021) Gustavo José Da Silva Pereira [Brésil] ; Anderson Henrique França Figueredo Leão [Brésil] ; Adolfo Garcia Erustes [Brésil] ; Ingrid Beatriz De Melo Morais [Brésil] ; Talita Aparecida De Moraes Vrechi [Brésil] ; Lucas Dos Santos Zamarioli [Brésil] ; Cássia Arruda Souza Pereira [Brésil] ; Laís De Oliveira Marchioro [Brésil] ; Letícia Paulino Sperandio [Brésil] ; Ísis Valeska Freire Lins [Brésil] ; Mauro Piacentini [Italie] ; Gian Maria Fimia [Italie] ; Patrícia Reckziegel [Brésil] ; Soraya Soubhi Smaili [Brésil] ; Claudia Bincoletto [Brésil]Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19.
000292 (2021) Hesham Refaat [Égypte] ; Fatma M. Mady [Égypte] ; Hatem A. Sarhan [Égypte] ; Heba S. Rateb [Égypte] ; Eman Alaaeldin [Égypte]Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19.
000326 (2021) C N Prashantha [Inde] ; K. Gouthami [Inde] ; L. Lavanya [Inde] ; Sivaramireddy Bhavanam [Inde] ; Ajay Jakhar [Inde] ; R G Shakthiraju [Inde] ; V. Suraj [Inde] ; K V Sahana [Inde] ; H S Sujana [Inde] ; N M Guruprasad [Inde] ; R. Ramachandra [Inde]Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
000333 (2021) Arif Ali [Inde] ; Nasim Sepay [Inde] ; Mohd Afzal [Arabie saoudite] ; Nayim Sepay [Inde] ; Abdullah Alarifi [Arabie saoudite] ; M. Shahid [Inde] ; Musheer Ahmad [Inde]Molecular designing, crystal structure determination and in silico screening of copper(II) complexes bearing 8-hydroxyquinoline derivatives as anti-COVID-19.
000346 (2021) Hardeep Singh Tuli [Inde] ; Shivani Sood ; Jagjit Kaur [Australie] ; Pawan Kumar [Israël] ; Prachi Seth ; Sandeep Punia [Inde] ; Priya Yadav [Inde] ; Anil Kumar Sharma [Inde] ; Diwakar Aggarwal [Inde] ; Katrin Sak [Estonie]Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements.
000355 (2021) Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.
000372 (2021) Jyoti Choudhary [Inde] ; Shrivardhan Dheeman [Inde] ; Vipin Sharma [Inde] ; Prashant Katiyar [Inde] ; Santosh Kumar Karn [Inde] ; Manoj Kumar Sarangi [Inde] ; Ankit Kumar Chauhan [Inde] ; Gaurav Verma [Inde] ; Nitin Baliyan [Inde]Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review.
000395 (2021) Suresh Kumar [Inde] ; Priya Kashyap [Inde] ; Suman Chowdhury [Inde] ; Shivani Kumar [Inde] ; Anil Panwar [Inde] ; Ashok Kumar [Inde]Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication.
000402 (2021) Tianling Ou [États-Unis] ; Huihui Mou [États-Unis] ; Lizhou Zhang [États-Unis] ; Amrita Ojha [États-Unis] ; Hyeryun Choe [États-Unis] ; Michael Farzan [États-Unis]Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2.
000428 (2021) A A Kamalov [Russie] ; V Yu Mareev [Russie] ; Ya A. Orlova [Russie] ; A G Plisyk [Russie] ; Z A Akopyan [Russie] ; Yu V. Mareev [Royaume-Uni] ; E A Mershina [Russie] ; Yu L. Begrambekova [Russie] ; P V Pakhomov [Russie]Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study.
000466 (2021) Iram Iqbal Hejazi [Inde] ; Md Amjad Beg [Inde] ; Md Ali Imam [Inde] ; Fareeda Athar [Inde] ; Asimul Islam [Inde]Glossary of phytoconstituents: Can these be repurposed against SARS CoV-2? A quick in silico screening of various phytoconstituents from plant Glycyrrhiza glabra with SARS CoV-2 main protease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "protein" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "protein" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    protein
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021